Skip to main content

Table 3 Correlation between plasma Lp-PLA2 and (1) CSF biomarkers for AD and (2) Schelten Score for white matter changes

From: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

  -ß- amyloid(1-42) P-Tau (181P epitope) T-Tau Schelten Score
  r ( P ) r ( P ) r ( P ) r ( P )
AD ( n = 78) -0.01 (0.91) -0.20 (0.08) -0.10 (0.40) -0.03 (0.82)
aMCI ( n = 59) -0.29 (0.03) -0.08 (0.54) -0.14 (0.28) 0.20 (0.12)
Normal controls
( n = 28 (CSF tests); n = 66 (Scheltens))
-0.17 (0.39) 0.35 (0.07) 0.27 (0.16) -0.06 (0.63)
  1. Correlations with P- value < 0.05 are presented in bold.